Mouse anti Human CD25, conjugated with FITC
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Mouse anti Human CD25, conjugated with FITC
Background:
Identification of Human receptor for Interleukin-2 (IL-2R) expressing the 55,000 M.W. surface antigen.Synonyms:
CD25 FITCUniProt:
P01589Host:
MouseSpecies Reactivity:
HumanIsotype:
IgG1Clone:
ITYVConjugation:
FITCType:
Single-Color ReagentApplications:
Flow CytometryField of Research:
Flow CytometryPurification Method:
Protein A/G ChromatographyAssay Principle:
PBMC: Add10 µL of MAB/10^6 PBMC in 100 µL PBS. Mix gently and incubate for 15 minutes at 2º to 8ºC. Wash twice with PBS and analyze or fix with 0.5% v/v of paraformaldehyde in PBS and analyze. WHOLE BLOOD: Add10 µL of MAB/100 µL of whole blood. Mix gently and incubate for 15 minutes at room temperature 20ºC. Lyse the whole blood. Wash once with PBS and analyze or fix with 0.5% v/v of paraformaldehyde in PBS and analyze. See instrument manufacturer’s instructions for Lysed Whole Blood and Immunofluorescence analysis with a flow cytometer or microscope.Stability:
See expiration date on vialConcentration:
Titered for flow cytometryForm:
Provided as solution in phosphate buffered saline with 0,08% sodium azide and 0,2% carrier proteinPrecautions:
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving Humans or animals.References & Citations:
1. A Monoclonal Antibody (Anti-Tac) Reactive with Activated and Functionally Mature Human T Cells. Uchiyama T., Broder S., Waldmann TA, 1981 J. Immunol.126,1393. 2. Direct Demonstration of the Identity of T Cell Growth Factor Binding Protein and the Tac Antigen. Robb RJ, Greene WC, J. Exp. Med. 1983,158;1332. 3. Patients with HIV infection have a reduced proportion of lymphocytes expressing the IL2 receptor p55 chain (TAC, CD25). Zola H., Koh L.Y., Mantzioris B.X., Rhodes D., Clin. Immunol. Immunopathol. 1991 Ap:59(1):16-25. 4. Spontaneous lymphocyte proliferation in HTLV-I/II infection reflects preferential activation of CD8 and CD16/56 cell subsets. Prince H.E., Weber D.M., Jensen E.R., Clin. Immunol. Immunopathol. 1991, May;58(3):419-30. 5. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+ CD8+ DR+ CD25- T cell population. Pantaleo G., Keonig S., Baseler M., Lane H.C., Fauci A.S., J. Immunol. 1990 Mar ; 144(5):1696-704.Shipping Conditions:
Room TemperatureStorage Conditions:
Product should be stored at 4-8ºC; DO NOT FREEZEFunctional Analysis:
Flow Cytometry StainingCAS Number:
9007-83-4
